Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Epsilon Energy (EPSN) Gains from Sales and Divestitures (2018 - 2025)

Epsilon Energy has reported Gains from Sales and Divestitures over the past 8 years, most recently at $267461.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 15.98% year-over-year to $267461.0; the TTM value through Dec 2025 reached $267461.0, up 15.98%, while the annual FY2025 figure was $267461.0, 15.98% up from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $267461.0 at Epsilon Energy, up from $49808.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $267461.0 in Q4 2025 and troughed at $8639.0 in Q2 2025.
  • A 5-year average of $108228.1 and a median of $90393.0 in 2022 define the central range for Gains from Sales and Divestitures.
  • Biggest five-year swings in Gains from Sales and Divestitures: skyrocketed 200.01% in 2021 and later plummeted 53.81% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $137668.0 in 2021, then decreased by 1.45% to $135667.0 in 2022, then rose by 21.78% to $165220.0 in 2023, then surged by 39.58% to $230618.0 in 2024, then rose by 15.98% to $267461.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for EPSN at $267461.0 in Q4 2025, $49808.0 in Q3 2025, and $8639.0 in Q2 2025.